Concepedia

Briggs Morrison

BM

Statistics

Publications

18

Citations

1.8K

H-Index

17

Active since

1953

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Pfizer (United States)

University of Pennsylvania

AstraZeneca (United States)

Harvard University

Briggs Morrison is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and clinical trials.

Publications per year

1953–2013

18

Publications

18

Effects of Specific Inhibition of Cyclooxygenase-2 on Sodium Balance, Hemodynamics, and Vasoactive Eicosanoids

Francesca Catella-Lawson, Brendan McAdam, Briggs Morrison et al. · Journal of Pharmacology and Experimental Therapeutics · 1999 · 595 citations

, , +16

Breast cancer–associated antigen, DF3/MUC1, induces apoptosis of activated human T cells

Claude Gimmi, Briggs Morrison, B. Mainprice et al. · Nature Medicine · 1996 · 164 citations

, , +11

Mat-8, a Novel Phospholemman-like Protein Expressed in Human Breast Tumors, Induces a Chloride Conductance in Xenopus Oocytes

Briggs Morrison, J. Randall Moorman, Gopal C. Kowdley et al. · Journal of Biological Chemistry · 1995 · 150 citations · Full text

, , +13

Effect of specific COX-2 inhibition in osteoarthritis of the knee: a 6 week double blind, placebo controlled pilot study of rofecoxib. Rofecoxib Osteoarthritis Pilot Study Group.

Elliot Ehrich, Thomas J. Schnitzer, Harris McIlwain et al. · PubMed · 1999 · 148 citations

, , +13

Preclinical and clinical pharmacodynamic assessment of L-778,123, a dual inhibitor of farnesyl:protein transferase and geranylgeranyl:protein transferase type-I.

Robert B. Lobell, Dongming Liu, Carolyn A. Buser et al. · PubMed · 2002 · 121 citations

, , +14

1–5 of 18